InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（7 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
7
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Van Tuyl Christopher, Directeur Juridique. Officer active across 1 company, notably Immunovant, Inc.. Cumulatively, 11 filings have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €409k. Activity tracked since 16 December 2024. The latest transaction was disclosed on 8 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Van Tuyl Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
1,143 股@ US$39.530.0006% mcap9.7% 占其流量Common StockSEC:0001764013-26-000082:0
63 股@ US$39.990.0000% mcap0.5% 占其流量Common StockSEC:0001764013-26-000082:1
17,824 股Common StockSEC:0001764013-26-000073:0
14,982 股Common StockSEC:0001764013-26-000073:1
2,842 股Common StockSEC:0001764013-26-000073:2
5,165 股@ US$24.830.0020% mcap15.0% 占其流量Common StockSEC:0001779707-26-000004:0
41,343 股0Common StockSEC:0001764013-26-000036:0
2,877 股@ US$24.970.0011% mcap8.5% 占其流量Common StockSEC:0001764013-26-000015:0
8,529 股@ US$26.780.0035% mcap26.5% 占其流量Common StockSEC:0001764013-25-000163:0
50,787 股0Common StockSEC:0001764013-25-000059:0
109,956 股0Common StockSEC:0001764013-24-000204:0
11 条申报中的 11 条
About Van Tuyl Christopher
Van Tuyl Christopher serves as Chief Legal Officer at Immunovant, Inc. In this role, he is responsible for managing the company's legal affairs, including compliance and risk management. His expertise in business law enables him to provide strategic advice to management and protect the company's interests. Christopher plays a key role in formulating internal policies and managing litigation.
